ALS

When ALS Changes Your Future, You Deserve to Know What’s Being Explored.

When you’re facing ALS, you have a lot to deal with—and a lot to figure out. You may be searching late at night, jumping from one study to another, trying to understand what is real, what is promising, and what may simply be hype.

We believe you shouldn’t have to sort through all of that alone.

We’ve gathered some of the most relevant research on Regenerative Medicine and ALS into one concise collection, with brief explanations and links to the original studies.

Why request it?

Because you don’t want to miss something important.

Because the amount of information online can be confusing and overwhelming.

Because your time is valuable—and you already have enough on your plate.

And because you deserve information that is balanced, not one-sided.

The collection includes encouraging human research—such as studies exploring motor-neuron protection, neurotrophic factors, cellular signaling, inflammation and even potential effects on disease progression and survival—alongside studies that have produced neutral or inconclusive results.

For example:

• A 2026 systematic review of 31 clinical studies found preliminary evidence that cell-based therapies may slow functional decline in ALS, while emphasizing that larger controlled trials are still needed.

• A long-term human study reported findings suggesting that mesenchymal stromal cell treatment may be associated with slower progression and longer survival.

• A human Phase 1/2a study demonstrated that engineered neural progenitor cells could continue producing the neurotrophic factor GDNF in the spinal cord for up to 42 months after transplantation.

• Newer research is also exploring exosomes and extracellular vesicles—the biological messages released by cells—as a way of potentially influencing the environment surrounding vulnerable motor neurons.

We want you to see what the research actually says—including its limitations.

Request our complimentary ALS & Regenerative Medicine Research Collection and use it as a starting point for your own research, your conversations with your physicians, and the decisions that are right for you.

No obligation. No pressure. Just information you may not want to miss.